Alpha 1 antitrypsin for preventing CPB machine damage

  • Category: Pharma
  • Investment Status: Advanced
  • Medical Field: Cardio-Vascular
  • Patent Status: National Phase
  • Development Status: clinical POC
  • Medical Center: Soroka Medical Center
  • Inventors: Dr. Dan Abramov

Background: Cardiopulmonary bypass (CPB) is one of the most  common surgical procedure performed on the heart. This kind of surgery  can profoundly alter haemostasis, predisposing patients to major CNS, haemorrhagic complications and possibly early bypass conduit-related thrombotic events as well.

Technology: Effective method of treating post operative complications during cardio-pulmonary surgery by administering alpha-1 antitrypsin (AAT).